Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R van Koningsveld

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Neurology|September 26, 2006
Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndromeM P J Garssen, R Van Koningsveld, P A Van Doorn
Epidemiology and Infection|February 24, 2001
Health burden in the Netherlands due to infection with thermophilic Campylobacter sppA H Havelaar, M A de Wit, R van Koningsveld, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 22, 2008
Recurrent Guillain-Barré syndromeK Kuitwaard, R van Koningsveld, L Ruts, et al.
The Cochrane Database of Systematic Reviews|April 21, 2006
Corticosteroids for Guillain-Barré syndromeR A C Hughes, A V Swan, R van Koningsveld, et al.
Neurology|February 27, 2001
Changes in referral pattern and its effect on outcome in patients with Guillain-Barré syndromeR Van Koningsveld, P A Van Doorn, P I Schmitz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 12, 1998
Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) groupI S Martina, R van Koningsveld, P I Schmitz, et al.
Neurology|February 19, 2000
Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The NetherlandsR Van Koningsveld, P A Van Doorn, P I Schmitz, et al.
Lancet (London, England)|January 24, 2004
Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trialR van Koningsveld, P I M Schmitz, F G Avander Meché, et al.
Neurology|January 12, 2005
HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndromeK Geleijns, G M Th Schreuder, B C Jacobs, et al.
Neurology|February 28, 2002
Infections and course of disease in mild forms of Guillain-Barré syndromeR Van Koningsveld, P I M Schmitz, C W Ang, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Neurology|September 26, 2006
Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndromeM P J Garssen, R Van Koningsveld, P A Van Doorn
Epidemiology and Infection|February 24, 2001
Health burden in the Netherlands due to infection with thermophilic Campylobacter sppA H Havelaar, M A de Wit, R van Koningsveld, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 22, 2008
Recurrent Guillain-Barré syndromeK Kuitwaard, R van Koningsveld, L Ruts, et al.
The Cochrane Database of Systematic Reviews|April 21, 2006
Corticosteroids for Guillain-Barré syndromeR A C Hughes, A V Swan, R van Koningsveld, et al.
Neurology|February 27, 2001
Changes in referral pattern and its effect on outcome in patients with Guillain-Barré syndromeR Van Koningsveld, P A Van Doorn, P I Schmitz, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 12, 1998
Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy. European Inflammatory Neuropathy Cause and Treatment (INCAT) groupI S Martina, R van Koningsveld, P I Schmitz, et al.
Neurology|February 19, 2000
Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The NetherlandsR Van Koningsveld, P A Van Doorn, P I Schmitz, et al.
Lancet (London, England)|January 24, 2004
Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trialR van Koningsveld, P I M Schmitz, F G Avander Meché, et al.
Neurology|January 12, 2005
HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndromeK Geleijns, G M Th Schreuder, B C Jacobs, et al.
Neurology|February 28, 2002
Infections and course of disease in mild forms of Guillain-Barré syndromeR Van Koningsveld, P I M Schmitz, C W Ang, et al.
Pageof 2